Bristol-Myers Squibb Company /
Orbital Therapeutics, Inc.
Bristol-Myers Squibb completes acquisition of Orbital Therapeutics
Source for the buyer and target: Beam Therapeutics Inc.
For the buyer and target.
“On December 8, 2025, Bristol-Myers Squibb Company (“BMS”) completed its previously announced acquisition of Orbital Therapeutics, Inc. (“Orbital”) pursuant to an Agreement and Plan of Merger dated October 10, 2025 between Orbital and BMS (the “Acquisition”).”
Published 11 Dec 2025
Open the sourceWhat happened
Bristol-Myers Squibb Company completed its acquisition of Orbital Therapeutics, Inc. on Dec. 8, 2025. [01]
Beam Therapeutics Inc. said its Orbital shares converted into $255.1 million in closing cash consideration, with the right to receive up to approximately $26.3 million in additional cash consideration upon the release of certain escrows. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Bristol-Myers Squibb completes acquisition of Orbital Therapeutics
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Closed
“Bristol-Myers Squibb completes acquisition of Orbital Therapeutics Bristol-Myers Squibb Company completed its acquisition of Orbital Therapeutics, Inc. on Dec. 8, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly